Ceren Unal

Ceren Unal

Auto-generated profile, based on publicly available information

Ceren Unal

Koc University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2023 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Open access
ECEbru Celik
Ebru Celik
AYAbdullah Burak Yildiz
Abdullah Burak Yildiz
SCSebile Guler Cekic
Sebile Guler Cekic
CUCeren Unal
Ceren Unal
IAIsil Ayhan
Isil Ayhan
TGTugba Gursoy
Tugba Gursoy
This meta-analysis aims to review the effect of serial transabdominal amnioinfusion (TAI) on short-term and long-term perinatal outcomes in mid-trimester preterm premature rupture of membranes (PPROM). Literature searches of PubMed, Web of Sciences, Scopus, and Cochrane Library were performed from their inception to April 2022. Studies comparing conventional treatment with serial TAI in women with proven PPROM at less than 26 + 0 weeks of gestation with oligohydramnios were included. Studies that included oligohydramnios due to other reasons such as fetal growth retardation or renal anomalies were excluded. Risk of bias in observational studies was assessed using the tool of the Cochrane Review group identified as risk of bias in non-randomized studies - of interventions. The risk of bias assessments for RCTs were performed according to the Cochrane risk-of-bias tool for randomized trials. An I2 score was used to assess the heterogeneity of included studies. The analyses were performed by using random-effect model, and the results were expressed as relative risk (RR) or mean difference with 95% confidence intervals (CIs). Overall, eight relevant studies including five observational studies (n = 252; 130 women allocated to the intervention) and three RCTs (n = 183; 93 women allocated to the intervention) were eligible. The pooled latency period was 21.9 days (95% CI, 13.1-30.8) and 5.8 days (95% CI, -11.6-23.2) longer in the TAI group in the observational studies and RCTs, respectively. The perinatal mortality rate reduced in the intervention group when tested in observational studies (RR 0.68; 95% CI, 0.51-0.92), but not in RCTs (RR 0.79; 95% CI, 0.56-1.13). The rate of long-term healthy survival was higher in the children whose mothers were treated with the TAI (35.7%) than those were treated with the standard management (28.6%) (RR 1.30, 95% CI 0.47-3.60, "best case scenario"). The efficacy of serial TA on early PPROM associated morbidity and mortality is not attested. Additional randomized control trials with adequate power are needed.

26 June 2025 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
ECE. Celik
E. Celik
GOG. Ozcan
G. Ozcan
CVCansel vatansever
Cansel vatansever
EPE. Paerhati
E. Paerhati
LUL. Uygur
L. Uygur
FCFüsun Can
Füsun Can
Objectives: A short cervix is a known risk factor for preterm birth, and imbalances in the vaginal microbiome, such as low relative abundance of Lactobacillus , may be associated with an increased risk of preterm birth. The aim of this study was to evaluate differences in the vaginal microbiome between women with a short cervix and those with normal cervical length in the second trimester. Additionally, we aimed to assess longitudinal changes in microbial diversity during pregnancy, as well as the impact of vaginal progesterone treatment on vaginal microenvironment in women with a short cervix. Methods: This was a prospective, longitudinal study conducted at Koc University Hospital between January 2020 and May 2023, in women with a singleton pregnancy with a short cervical length (≤ 25 mm) in the second trimester (20 + 0 to 24 + 6 weeks' gestation). After diagnosis of short cervix, administration of 200 mg vaginal progesterone daily was initiated. The control group comprised women with a normal cervical length (> 25 mm) in the second trimester, matched for age and body mass index (BMI). Cervicovaginal swabs were collected from the posterior fornix at three gestational‐age ranges: in the first trimester (11 + 0 to 13 + 6 weeks), the second trimester (20 + 0 to 24 + 6 weeks) and the third trimester (28 + 0 to 34 + 6 weeks), and cervical length was measured following sample collection. DNA was extracted and the 16S rRNA bacterial gene was sequenced to analyze and compare the vaginal microbiome between women with a short cervix and controls. We also assessed the microbiome longitudinally in each group, across the first, second and third trimesters. In the short‐cervix group, we also compared the microbiome before initiation of progesterone treatment in the second trimester and 4 weeks after its initiation. Results: Among 490 pregnant women who underwent first‐trimester screening during the study period and had vaginal swabs collected, short cervical length was detected in 31 at the second‐trimester scan. These women formed the study group. A further 27 women, with a normal cervical length, were matched for BMI and age and assigned to the control group. During the second trimester, women with a short cervix exhibited greater species diversity compared with the control group; this was suggested by the higher Shannon index (0.45 vs 0.33; P = 0.135), which reflects species richness and evenness, and further demonstrated by the higher Chao index (20.2 vs 13.8; P = 0.018), which estimates species richness. In the second trimester, Lactobacillus was less abundant in women with a short cervix than in the control group, although the difference did not reach significance (86.8% vs 95.5%; P = 0.091). At the phylum level, in women with a short cervix compared to those with normal cervical length, the relative abundance of Firmicutes, to which the genus Lactobacillus belongs, was significantly lower (90.7% vs 97.6%; P = 0.041), while the relative abundances of both Bacteroidota (1.73% vs 0.4%; P = 0.004) and Proteobacteria (0.2% vs 0.01%; P = 0.007) were higher. In the second trimester, the relative abundance of Lactobacillus gasseri was significantly lower in women with a short cervix compared to controls (4.7% vs 13.8%; P = 0.023). In the longitudinal analysis of the vaginal microbiome, there were no significant differences among the trimesters in the control group. In contrast, in those with a short cervix, there was a notable decrease in the amount of Lactobacillus crispatus , from 55.0% in the first trimester to 36.1% in the second trimester ( P = 0.052). In women with a short cervix, there was no significant difference in bacterial diversity after vs before progesterone treatment (Chao index, 22.6 vs 20.5; P = 0.609). Conclusion: These findings highlight the significant alterations in the vaginal microbiome of pregnant women with a short cervix in comparison to those with normal cervical length, particularly in terms of higher species diversity and distinct community composition. The study also shows that vaginal progesterone treatment in women with a short cervix does not alter the vaginal microbiome, suggesting that it is a safe and effective intervention without disrupting the vaginal microbial balance. Understanding the relationship between cervical length and the vaginal microbiome is essential for developing strategies to reduce the risk of preterm birth in high‐risk populations. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

10 February 2026 in Research Square
Verified
Preprint
Open access
SCSebile Guler Cekic
Sebile Guler Cekic
CUCeren Unal
Ceren Unal
CBCan Benlioglu
Can Benlioglu
MOM. Atay Ozten
M. Atay Ozten
MTMert Turgal
Mert Turgal
ECEbru Celik
Ebru Celik
Background The purpose of the study is to evaluate whether the change in cervical length (ΔCx) between the first and second trimesters can predict spontaneous preterm birth (sPTB) in women with a normal mid-trimester cervical length (CL > 25 mm). The study also aimed to explore the relationship between cervical dynamics and maternal characteristics -age, body mass index (BMI) and smoking status- on the prediction of sPTB in a low-risk cohort. Methods This prospective longitudinal cohort study included singleton pregnancies with first- and second-trimester transvaginal CL measurements > 25 mm. CL was measured at 11–14 (C1) and 18–24 weeks (C2). ΔCx was calculated as C2 − C1, and the rate of cervical change (slope) as (C2 − C1) divided by the gestational age interval between scans (mm/week). The primary outcome was sPTB < 37 weeks. Multivariable logistic regression was used to assess associations between CL parameters and sPTB, adjusting for maternal age, BMI and smoking. Nested models were compared to evaluate whether longitudinal cervical change added predictive value beyond second-trimester CL. Results A total of 2,317 women met inclusion criteria. The overall rate of sPTB was 8.24% before 37 weeks, and 0.52% delivered before 34 weeks. First-trimester CL was similar in term and preterm pregnancies (35.7 ± 4.6 mm vs 35.4 ± 4.7 mm, p = 0.44), as was second-trimester CL (37.4 ± 5.5 mm vs 36.7 ± 5.5 mm, p = 0.08). Mean ΔCx did not differ significantly between groups (1.68 ± 7.18 mm in term vs 1.29 ± 6.71 mm in preterm, p = 0.44), and the distribution of rate of cervical change (mm/week) overlapped substantially between term and preterm births. In multivariable analysis, neither ΔCx nor rate of cervical change was independently associated with sPTB, and adding slope did not improve model performance beyond second-trimester CL. Conclusions In women with a normal first- and mid-trimester cervix (CL > 25 mm), ΔCx-whether expressed as absolute difference or rate of change- does not meaningfully predict sPTB or enhance risk stratification beyond a single second-trimester CL measurement. These findings support continued reliance on mid-trimester transvaginal CL as the key sonographic screening tool in low-risk populations.

21 August 2026 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
LULütfiye Uygur
Lütfiye Uygur
ATAbdullah Tabakçı
Abdullah Tabakçı
IAIşıl Ayhan
Işıl Ayhan
HSHazal Sağkol
Hazal Sağkol
CUCeren Unal
Ceren Unal
MÖMucize Eriç Özdemir
Mucize Eriç Özdemir

30 September 2024 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
CUCeren Unal
Ceren Unal
SÇSebile Güler Çekiç
Sebile Güler Çekiç
PBPınar Bulutay
Pınar Bulutay
ŞTŞevval Berfin Topkara
Şevval Berfin Topkara
BGBurak Giray
Burak Giray

16 July 2025 in The American Journal of Dermatopathology
Verified
Journal Article
Closed access
CUCeren Unal
Ceren Unal
SCSebile Guler Cekic
Sebile Guler Cekic
ZGZuhal Gucin
Zuhal Gucin
SASerdar Aydin
Serdar Aydin
Pseudoangiomatous stromal hyperplasia (PASH) is a benign myofibroblastic proliferation frequently encountered in the breast but rarely affects anogenital mammary-like glands, where it typically presents as small nodules. We report a rare case of a 38-year-old woman who developed a 95 × 60 × 60-mm vulvar mass 4 months after undergoing bilateral mastectomy and axillary excisions for histologically confirmed PASH. Pelvic MRI revealed a well-circumscribed, hypointense lesion in the posterolateral vaginal wall. Wide local excision was performed. Histopathology demonstrated a dense collagenous stroma with bland spindle cells forming interanastomosing slit-like, endothelial-free pseudovascular spaces, confirming the diagnosis of PASH. No fibroadenomatous component was observed. Immunohistochemical staining was positive for SMA and negative for CD31 and Factor VIII in the pseudovascular spaces, aiding in the exclusion of vascular neoplasms such as angiosarcoma. The patient remains recurrence-free at 1 year. This case highlights the potential for delayed multifocal PASH involving hormonally responsive anogenital sites, emphasizes its inclusion in the differential diagnosis of large vulvar masses, and underscores the need for surveillance of ectopic mammary-like tissues in patients with a history of PASH.